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Abstract
The additive under assessment, ferric oxide, contains between 57% and 69% iron (Fe). The EFSA
FEEDAP Panel could not conclude on the safety of ferric oxide for the target animals owing to that
(i) the application of ferric oxide red is for all animal species, (ii) lifetime administration to animals is
not excluded and (iii) a sufﬁcient biological and toxicological database was not available. Regarding
(i) the very low absorption of iron from the ferric oxide by target animals and (ii) the homoeostatic
regulation of iron metabolism in animals, any inﬂuence of feeding the ferric oxide on the iron content
of edible tissues and products is not expected. The use of ferric oxide in animal nutrition is unlikely to
result in a direct exposure of the consumer to this oxide. Consequently, the supplementation of feed
for food-producing animals with ferric oxide would likely not constitute a risk to consumers. Ferric
oxide is an irritant to skin and eyes by mechanical action. Owing to the nickel content in the additive,
the ferric oxide should be regarded as dermal and respiratory sensitiser. Inhalation of ferric oxide, and
the contained chromium and nickel, is a hazard; as exposure by inhalation is likely, handling ferric
oxide would be a risk for the users. As there is concern about the possible genotoxicity of ferric oxide,
any route of exposure should be considered as hazardous. Iron oxides are ubiquitous in the
environment. Any additional input from the nutritional use of ferric oxide in food-producing animals is
considered negligible. It is unlikely that the use of the additive in animal nutrition would pose a risk to
the environment. Ferric oxide should not be considered as iron source capable to meet iron
requirements of animals.
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Summary
Following a request from the European Commission, the Panel on Additives and Products or
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientiﬁc opinion on safety and
efﬁcacy of ferric oxide as feed additive for all animal species.
Three manufacturing routes are described for ferric oxide: mining, synthetic and derusting. It
contains between 57% and 66% (mining), 68% (synthetic) and 69% (derusting) iron (Fe).
The FEEDAP Panel could not conclude on the safety of ferric oxide for the target animals owing to
that (i) the application of ferric oxide red is for all animal species, (ii) lifetime administration to animals
is not excluded and (iii) a sufﬁcient biological and toxicological database was not available.
Regarding (i) the very low absorption of iron from the ferric oxide by target animals and (ii) the
homoeostatic regulation of iron metabolism in animals, any inﬂuence of feeding the ferric oxide on the
iron content of edible tissues and products is not expected. The use of ferric oxide in animal nutrition
is unlikely to result in a direct exposure of the consumer to this oxide. Consequently, the
supplementation of feed for food-producing animals with ferric oxide would likely not constitute a risk
to consumers.
Ferric oxide is an irritant to skin and eyes by mechanical action. Owing to the nickel content in the
additive, the ferric oxide should be regarded as dermal and respiratory sensitiser. Inhalation of ferric
oxide, and the contained chromium and nickel, is a hazard; as exposure by inhalation is likely, handling
ferric oxide would be a risk for the users. As there is concern about the possible genotoxicity of ferric
oxide, any route of exposure should be considered as hazardous.
Iron oxides are ubiquitous in the environment. Any additional input from the nutritional use of ferric
oxide in food-producing animals is considered negligible. It is unlikely that the use of the additive in
animal nutrition would pose a risk to the environment.
Ferric oxide should not be considered as iron source capable to meet iron requirements of animals.
The FEEDAP Panel made some recommendations concerning the denomination of the additive and
its speciﬁcations.
Ferric oxide for all animal species
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 10(2) of that Regulation also speciﬁes that for
existing products within the meaning of Article 10(1), an application shall be submitted in accordance
with Article 7, at the latest 1 year before the expiry date of the authorisation given pursuant to
Directive 70/524/EEC for additives with a limited authorisation period, and within a maximum of
7 years after the entry into force of this Regulation for additives authorised without a time limit or
pursuant to Directive 82/471/EEC.
The European Commission (EC) received a request from Poortershaven Industri€ele Mineralen B.V.2
for re-evaluation of the authorisation of the iron-containing additive, ferric oxide, when used as a feed
additive for all animal species (category: nutritional additive; functional group: compound of trace
elements).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 10(2)
(re-evaluation of an authorised feed additive). EFSA received directly from the applicant the technical
dossier in support of this application. The particulars and documents in support of the application were
considered valid by EFSA as of 24 May 2012.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment, and on the efﬁcacy of ‘Ferric
oxide’, when used under the proposed conditions of use (see Section 3.1.2).
1.2. Additional information
Iron (Fe) is the most abundant trace element in mammals. It serves as a constituent in proteins
(e.g. haemoproteins: haemoglobin, myoglobin; non-haemoproteins: ferritin, transferrin) and as a
cofactor for many important iron-dependent enzymes (e.g. cytochromes A, B, C; peroxidases,
catalases). Haemoglobin makes up 70% of the entire iron body pool. The intestinal absorption of iron
and its retention is highly regulated via homeostasis (for reviews see Wessling-Resnick, 2000; Miret
et al., 2003; Fuqua et al., 2012). Iron is present in biological systems in one of the two oxidation
states, and redox interconversions of the ferrous (Fe(II)) and ferric (Fe(III)) forms are central to the
biological properties of this trace element. Aerobic metabolism depends on iron. As a constituent of
haemoglobin, it is involved in oxygen and carbon dioxide transport. It plays a central role as cofactor
for most of the enzymes of the Krebs cycle and functions as electron carrier (McDowell, 2003; Suttle,
2010; Ponka et al., 2015).
The additive ‘Ferric oxide’ had been authorised in the European Union (EU) under the element Iron-Fe
for all animal species ‘Without a time limit’ (Commission Regulation (EC) No 1334/20033
and amendments, and Commission Regulation (EC) No 479/2006)4. Following the provisions of Article 10
(1) of Regulation (EC) No 1831/2003, the compound was included in the EU Register of Feed Additives
under the category ‘Nutritional additives’ and the functional group ‘Compounds of trace elements’.5
EFSA issued an opinion on the safety of the chelated forms of iron, copper, manganese and zinc
with synthetic feed grade glycine (EFSA, 2005). In the frame of re-evaluation, EFSA has delivered ﬁve
opinions on iron-based additives: iron chelate of amino acids, hydrate (EFSA FEEDAP Panel, 2013,
2016a); ferrous sulfate, heptahydrate (EFSA FEEDAP Panel, 2014a, 2016a); ferrous sulfate,
monohydrate (EFSA FEEDAP Panel, 2014b, 2016a); ferrous carbonate (EFSA FEEDAP Panel, 2015,
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Poortershaven Industri€ele Mineralen, B.V. Wijnhaven 84, 3011 WT, Rotterdam, The Netherlands.
3 Commission Regulation (EC) No 1334/2003 of 25 July 2003 amending the conditions for authorisation of a number of additives
in feedingstuffs belonging to the group of trace elements. OJ L 187, 26.7.2003, p. 11.
4 Commission Regulation (EC) No 479/2006 of 23 March 2006 as regards the authorisation of certain additives belonging to the
group compounds of trace elements. OJ L 86, 24.3.2006, p. 4.
5 European Union Register of Feed Additives pursuant to Regulation (EC) No 1831/2003. http://ec.europa.eu/food/food/
animalnutrition/feedadditives/comm_register_feed_additives_1831-03.pdf
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2016a); ferric chloride, hexahydrate, ferrous fumarate, and ferrous chelate of glycine, hydrate (EFSA
FEEDAP Panel, 2016a).
In 2015, the EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) adopted a
scientiﬁc opinion on the re-evaluation of iron oxides and hydroxides (E 172) as food additives (EFSA
ANS Panel, 2015). Following that, the FEEDAP Panel adopted a scientiﬁc opinion on the safety and
efﬁcacy of iron oxide black, red and yellow for all animal species as colourings in feed (EFSA FEEDAP
Panel, 2016b).
A compilation of risk assessments carried out on iron and its compounds, including opinions from
EFSA Panels other than the FEEDAP Panel, is in Appendix A. A list of authorisations of iron compounds
in the EU, other than as feed additives, is reported in Appendix B.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier6 in support of the authorisation request for the use of ferric oxide as a feed additive. The
technical dossier was prepared following the provisions of Article 7 of Regulation (EC) No 1831/2003
Regulation (EC) No 429/20087 and the applicable EFSA guidance documents.
The FEEDAP Panel used the data provided by the applicant together with data from other sources,
such as previous risk assessments by EFSA or other expert bodies, scientiﬁc papers and other scientiﬁc
reports to deliver the present output.
EFSA commissioned the University of Gent (Belgium) to carry out a study on the biological role,
content in feed and requirements in animal nutrition of selected trace and ultratrace elements,
including iron. The ﬁndings were submitted to EFSA in the form of a technical report (Van Paemel
et al., 2010). Information from this report has been used in this opinion.
EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of iron (eight compounds, including ferric oxide) in animal feed. The
Executive Summary of the EURL report can be found in Annex A.8
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of ferric oxide is
in line with the principles laid down in Regulation (EC) No 429/2008 and the relevant guidance
documents: Guidance on nutritional additives (EFSA FEEDAP Panel, 2012a), Technical guidance:
Tolerance and efﬁcacy studies in target animals (EFSA, 2011), Technical Guidance for assessing
the safety of feed additives for the environment (EFSA, 2008a), Guidance for the preparation of
dossiers for the re-evaluation of certain additives already authorised under Directive 70/524/EEC
(EFSA, 2008b), Guidance for the preparation of dossiers for additives already authorised for use in
food (EFSA FEEDAP Panel, 2012b), Guidance for establishing the safety of additives for the consumer
(EFSA FEEDAP Panel, 2012c), and Guidance on studies concerning the safety of use of the additive for
users/workers (EFSA FEEDAP Panel, 2012d).
3. Assessment
The opinion is based on data provided by a company involved in the production/distribution of
ferric oxide and publicly available literature. In particular, the Opinion on the re-evaluation of iron
oxides and hydroxides (E 172) as food additives (EFSA ANS Panel, 2015) and the Opinions on iron-
based feed additives (EFSA FEEDAP Panel, 2013, 2014a,b, 2015, 2016a) and on iron oxide black, red
and yellow as colourings in feed (EFSA FEEDAP Panel, 2016b) were considered.
It should be recognised that these data cover only a fraction of the ferric oxide placed on the
market as compound of trace element.
6 FEED dossier reference: FAD-2010-0236.
7 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
8 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/default/ﬁles/FinRep-SANCO-Iron.pdf
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3.1. Characterisation
For compounds of trace elements, the element itself is considered the active substance.
3.1.1. Ferric oxide
3.1.1.1. Identity of the additive
‘Ferric oxide’ (Chemical Abstracts Service (CAS) no 1309-37-1) has the chemical formula Fe2O3
(molecular weight 159.69 Da; theoretical iron content 69.6%). It is a red brown powder.
Other chemical names are iron sesquioxide, anhydrous ferric oxide, and anhydrous iron (III) oxide.
Synonyms for ferric oxide as colourant (iron oxide red): CI Pigment Red 101; CI (1975) No 77491; INS
No 172(ii). Other names: hematite, ferric iron, red iron oxide, rouge, maghemite, colcothar, rust, ochre.
The applicant stated that iron oxides are on the market under different names and references. The
information given in the ﬁrst data set referred to 13 different products, named with in-house identiﬁers.9
In a supplementary information data set submitted to EFSA,10 the applicant clariﬁed that these products
could be assigned to each of four groups, three of them based on their origin and manufacturing process
(Group A – products obtained through extraction from nature; Group B – products made synthetically
from iron ﬂakes; and Group C – products made from derusting) and one which was composed of
products blends of different iron oxides. Further to that, the applicant submitted an amended Section II
of the Dossier ‘Identity, characterisation and conditions of use of the additive; methods of analysis’ in
which the products to be assessed were reduced to ﬁve, allocated to the groups deﬁned above as
follows11: Group A (‘A1’/‘A2’/‘A3’), Group B (‘B’) and Group C (‘C’). The products are presented as a red
brown powder, odourless; they are insoluble in water.12
Products obtained by extraction from natural sources
This group initially included the products ‘A1’, ‘A2’ and ‘A3’. After an in-depth examination of the
data submitted, and the request for clariﬁcation to the applicant, it was identiﬁed that there were two
manufacturing processes for the iron oxides of group A. One of them starting from dry ore and
subsequently crushed and milled results in the ‘iron oxide red’ (Fe2O3) subject of re-evaluation
(products ‘A1’ and ‘A2’).13 Product ‘A3’ is derived from another manufacturing process starting with a
slurry from natural iron ores, and giving ‘iron oxide black’ (FeOFe2O3). Therefore, only products ‘A1’
and ‘A2’ will be characterised below.
Concerning the iron and ferric oxide content of these products, the speciﬁcations provided were
≥ 55% and ≥ 76%, respectively, for ‘A1’14 and ≥ 64.5% and ≥ 93%, respectively, for ‘A2’.15 Analytical
data on total iron content determined by an X-Ray ﬂuorescence (XRF) resulted in 56.6% and 65.9% as
average of ﬁve and three batches for ‘A1’ and ‘A2’, respectively.16 Further to that, the content of
ferrous oxide was determined in one batch of each product with the analysis of the iron(II) in the
products by a potentiometric titration, giving the values of 0.45% and 0.55% for ‘A1’ and ‘A2’,
respectively; from the total iron content, the content of ferric oxide was calculated to be 76.8% and
92.89% in the ‘A1’ and ‘A2’, respectively.17
Levels of heavy metals (cadmium (Cd), lead (Pb), mercury (Hg)), arsenic (As) and ﬂuorine (F),
were analysed in one to four batches each of the two products. For the product ‘A1’, the following
results were reported (in mg/kg)18: Cd (three batches) < 0.01–< 0.10, Pb (four batches) 5.5–13, Hg
(three batches) 0.02–0.74, As (four batches) 6.1–14 and F (two batches) 48–234. For the product, ‘A2’
the following results were reported (in mg/kg)19: Cd (three batches) 0.03–< 0.10, Pb (three batches)
3.4–4.3, Hg (three batches) 0.04–< 0.10, As (three batches) 0.15–3.54 and F (one batch) 38. These
9 Technical Dossier/Section II.
10 Technical Dossier/Supplementary Information January 2013.
11 Corresponding to the following products, based on the in-house identiﬁers described in the Technical dossier: ‘A1’ to P5 (or
5P), ‘A2’ to S2-600, ‘A3’ to NM400; ‘B’ to P3B (or P3S); ‘C’ to BT98 (or bt98).
12 Technical Dossier/Supplementary Information March 2014.
13 Technical Dossier/Supplementary Information March 2015. 1.1 Flow.Chart.P5.S2.600.FeCO3.Range3.pdf.
14 Technical Dossier/Supplementary Information June 2015/Annex 3.3.
15 Technical Dossier/Supplementary Information June 2015/Annex 3.4.
16 Technical Dossier/Supplementary Information March 2014/Section_2_Fe2O3 140313.pdf. Technical Dossier/Supplementary
Information March 2015.
17 Technical Dossier/Supplementary Information June 2015/Annex 1.
18 Technical Dossier/Supplementary Information March 2014/Annex 2.1.4.a.
19 Technical Dossier/Supplementary Information March 2014/Annex 2.1.4.b.
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values comply with the thresholds set in Directive 2002/32/EC20 for compounds of trace elements or, if
not mentioned in the Directive, do not appear to represent a safety concern. The nickel content (three
batches each of product ‘A1’ and ‘A2’) showed an average of 9 and 67 mg/kg for ‘A1’ and ‘A2’,
respectively.21
Dioxins and the sum of dioxins plus dioxin-like polychlorinated biphenyls (PCBs) were analysed each
in three and one batches of ‘A1’ and ‘A2’, showing 0.018–0.07 and 0.025–0.17 ng WHO-PCDD/F-TEQ/kg
‘A1’ and ‘A2’, respectively, and 0.003 and 0.19 ng WHO-PCDD/F-PCB-TEQ/kg ‘A1’ and ‘A2’, respectively22;
these concentrations comply with those set in Directive 2002/32/EC.
In total, it appeared that the product ‘A1’ has a lower purity than the ‘A2’; the applicant stated that
the two products originate from two different ores, being that the reason for the different composition
and physical properties (e.g. loss in ignition: 8% for ‘A1’23 and 0.7% for ‘A2’).24 For products ‘A1’ and ‘A2’,
bulk density was determined to be 0.95 and 1.40 g/cm3, respectively, and density 4.4 and 5.0 kg/L,
respectively.25
Particle size distribution, giving the required dimensions, was measured by sieving one batch of the
product ‘A1’25 and four batches of product ‘A2’.26 Both products showed 100% (w/w) of the particles
below 50 lm, while the amount below 10 lm was 95% (w/w) in four out of ﬁve batches. Dusting
potential (Stauber–Heubach method), measured in three batches each of product ‘A1’ and ‘A2’, ranged
from 0.3 to 0.5 g/m3 for ‘A1’ and from 0.2 to 1.0 g/m3 for ‘A2’.27
Product obtained by synthesis
The product ‘B’ is produced by synthesis from iron ﬂakes.
For the production of iron oxide ‘B’, preparations of ferrous sulfate and ferrous nitrate are oxidised
under steam. The wet material is ﬁltered, rinsed, dried and sieved. The resulting product is the
pigment iron oxide red identical to the ferric oxide, subject of the current re-evaluation.12,28
Concerning the iron and ferric oxide content of ‘B’, the speciﬁcations provided were ≥ 67% and
≥ 95.5%, respectively.29 Analytical data on total iron content determined by an XRF resulted in 68.0%
as average of ﬁve batches; the calculated amount of ferric oxide was 97.2%.30
Levels of heavy metals (Cd, Pb, Hg), As and F, were analysed in two to three batches of the
product. The following results were reported (in mg/kg)31: Cd (three batches) 0.01–< 0.10, Pb (three
batches) 0.16–9.16, Hg (three batches) 0.01–< 0.10, As (three batches) 0.44–7.71 and F (two
batches) 6.9–40. These values comply with the thresholds set in Directive 2002/32/EC for compounds
of trace elements or, if not mentioned in the Directive, do not represent a safety concern. The nickel
content measured in one batch was 25 mg/kg.32
Dioxins and the sum of dioxins plus dioxin-like PCBs were analysed each in two and one batches of
the product, showing 0.024–0.028 ng WHO-PCDD/F-TEQ/kg B and 0.003 and 0.061 ng WHO-PCDD/F-
PCB-TEQ/kg ‘B’, respectively33; these concentrations comply with those set in Directive 2002/32/EC.
The bulk density was determined to be 0.80 g/cm3 and density 5.0 kg/L.25
Particle size distribution was measured by sieving in three batches of the product ‘B’34 showing
100% (w/w) of the particles below 10 lm. Dusting potential (Stauber–Heubach method) measured in
three batches ranged from 0.2 to 0.5 g/m3.35
20 Directive 2002/32/EC of the European Parliament and of the Council of 7 May 2002 on undesirable substances in animal feed.
OJ L 140, 30.5.2002, p. 10.
21 Technical Dossier/Supplementary Information March 2015/Annexes 4.1–4.6.
22 Technical Dossier/Supplementary Information March 2014/Annexes 2.1.4.f., 2.1.4.g. 2.1.4.h. and 2.1.4.i.
23 Technical Dossier/Supplementary Information March 2015/Annex 2.1.3.b.
24 Technical Dossier/Supplementary Information March 2015/Annex 2.1.3.d.
25 Technical Dossier/Supplementary Information March 2014/Annex 2.1.5.a.
26 Technical Dossier/Supplementary Information March 2014/Annexes 2.1.5.a. and 2.1.5.b.
27 Technical Dossier/Supplementary Information March 2015/Annexes 4.7–4.12.
28 As reported by the applicant, the manufacturing process could also provide the product ZBLM, an iron oxide yellow (FeO(OH)H2O,
CAS number 51274-00-1, MW: 88.85 (FeO(OH)).
29 Technical Dossier/Supplementary Information June 2015/Annex 3.2.
30 Technical Dossier/Supplementary Information March 2014/Section_2_Fe2O3 140313.pdf (Annex 2.1.3.h.). Technical Dossier/
Supplementary Information March 2015.
31 Technical Dossier/Supplementary Information March 2014/Annex 2.1.4.c.
32 Technical Dossier/Supplementary Information March 2014/Annex 2.1.4.e.
33 Technical Dossier/Supplementary Information March 2014/Annexes 2.1.4.k. and 2.1.4.l.
34 Technical Dossier/Supplementary Information March 2014/Annex 2.1.5.d.
35 Technical Dossier/Supplementary Information March 2014/Annex 2.4.3.c.
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Product obtained by derusting
The product ‘C’ is made from derusting. This iron source is then mixed with hydrochloric acid and
heated in a furnace under a stream of air. The hydrochloric acid is recycled and the resulting iron oxide
is stored.12
Concerning the iron and ferric oxide content of ‘C’, the speciﬁcations provided were ≥ 69% and
≥ 98.3%, respectively.36 Analytical data on total iron content determined by an XRF resulted in 69.2%
as average of ﬁve batches; the calculated amount of ferric oxide was 99.3%.37
Levels of heavy metals (Cd, Pb, Hg), As and F, were analysed in two to ﬁve batches of the
product. The following results were reported (in mg/kg)38: Cd (ﬁve batches) < 0.01–< 0.10, Pb (ﬁve
batches) 0.62–< 1.00, Hg (ﬁve batches) < 0.01–< 0.10, As (ﬁve batches) 0.03–0.53 and F (two
batches) < 5–35. These values comply with the thresholds set in Directive 2002/32/EC for compounds
of trace elements or, if not mentioned in the Directive, do not represent a safety concern. The nickel
and chromium content (three batches) showed an average of 107 mg/kg and 404 mg/kg,
respectively.39
Dioxins and the sum of dioxins plus dioxin-like PCBs were analysed each in four and two batches of
the product, showing 0.04–0.11 ng WHO-PCDD/F-TEQ/kg ‘C’ and 0.063–0.12 ng WHO-PCDD/F-PCB-
TEQ/kg ‘C’, respectively40; these concentrations comply with those set in Directive 2002/32/EC.
Particle size distribution was measured by sieving in three batches of the product ‘C’41 showing
100% (w/w) of the particles below 150 lm, and an average of 95.7% below 35 lm. Further, three
batches were examined for particle size distribution by a laser diffraction and the results provided were
on an average 57% (v/v) of particles below 50 lm and 25% (v/v) below 10 lm.42 Dusting potential
(Stauber–Heubach method) measured in two batches was 0.4 and 2.7 g/m3.43
The FEEDAP Panel notes that all particle size determinations, with the exception of three batches of
product ‘C’, were performed by a sieve analysis. The lowest particle size by this method is determined
by the availability of sieves with a certain diameter, particles below 10 lm cannot be separated in
further fractions. With a laser diffraction method, the micronised fraction can be measured (from
above 100 to below 1,000 nm). It varied for the three batches of ‘C’ between 2.2% and 3.7% (v/v).
No more data on the micronised fraction were available and no data at all would give information on a
potential nanofraction.
3.1.1.2. Stability and homogeneity
No stability data are required for inorganic compounds of trace elements.
No experimental data on homogenous distribution of the additive were provided.
3.1.2. Physicochemical incompatibilities in feed
According to the current knowledge, no incompatibilities resulting from the use of ferric oxide in
compound feed are expected, other than those widely known and considered by feed manufacturers in
diet formulation.
3.1.3. Conditions of use
The iron compound under application, ferric oxide, is intended to supply iron in ﬁnal feed for all
animal species/categories up to a maximum total content of 250 mg/day for piglets up to 1 week
before weaning,44 750 mg/kg complete feedingstuffs for other pigs, 500 mg/kg complete feedingstuffs
for ovines, 1,250 mg/kg complete feedingstuffs for pets and 750 mg/kg complete feedingstuffs for
other animal species.
36 Technical Dossier/Supplementary Information June 2015/Annex 3.1.
37 Technical Dossier/Supplementary Information March 2014/Section_2_Fe2O3 140313.pdf (Annex 2.1.3.i.). Technical Dossier/
Supplementary Information March 2015.
38 Technical Dossier/Supplementary Information March 2014/Annex 2.1.4.d.
39 Technical Dossier/Supplementary Information March 2015/Annexes 6.1 to 6.3.
40 Technical Dossier/Supplementary Information March 2014/Annex 2.1.4.m.
41 Technical Dossier/Supplementary Information March 2014/Annex 2.1.5.c.
42 Technical Dossier/Supplementary Information March 2015/Annexes 5.3–5.5.
43 Technical Dossier/Supplementary Information March 2015/Annexes 5.1 and 5.2.
44 It is noted that the units in the entry for piglets up to 1 week before weaning in the Proposal for Register Entry submitted by
the applicant are incorrect: 250 mg/kg complete feedingstuff, instead of 250 mg/day.
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3.2. Safety
3.2.1. Toxicological studies
No toxicity studies were produced by the applicant. In its recently published opinion on the safety
and efﬁcacy of iron oxides as colourings in animal nutrition, the FEEDAP Panel summarised the
toxicology of iron oides (EFSA FEEDAP Panel, 2016b) based on the above mentioned opinion of the
ANS Panel (EFSA ANS Panel, 2015). An extract of that opinion, particularly referring to the iron oxide
under assessment, is given below.
In 1974, Joint FAO/WHO Expert Committee on Food Additives (JECFA) allocated a ‘Temporary ADI
not speciﬁed’ to iron oxides and hydrated iron oxides due to the lack of information on physiological
absorption and iron storage following the use of iron oxides as food pigments. At the 1978 JECFA
meeting, this temporary acceptable daily intake (ADI) was extended until 1979. In 1980, an ADI of
0–0.5 mg/kg body weight (bw) per day was established (JECFA, 1980).
The available data indicate that absorption of iron from iron oxides is low. In rats, 0.01–2.3% of
the total oral dose of microsized red iron oxide (Fe2O3) was absorbed and distributed in different
organs or excreted in urine. Low absorption of iron (0.01%) from red iron oxide was observed in
humans receiving a diet containing red iron oxide, whereas a higher absorption of yellow iron oxide
(1.5–2.4% of the dose) was described in similar populations. In these human studies, the addition of
ascorbic acid increased by 5–50 times the iron absorption rates from diets containing either red iron
oxide (Fe2O3) or yellow iron oxide (FeO(OH)). The Panel noted that there are no data regarding the
biological fate of microparticles of black iron oxide (FeOFe2O3).
Concerning toxicological studies, the Panel noted that there is a lack of information on the presence
of nanoparticles in iron oxides used in most of the old studies. Regarding acute toxicity, the available
data indicate that iron oxides and hydroxides are of low toxicity in rats and mice.
The subacute oral toxicities of nano red iron oxide (Fe2O3-30 nm) and microsized red iron oxide
(Fe2O3-Bulk) were compared in rats given 0, 30, 300 or 1,000 mg/kg bw per day for 28 days (Kumari
et al., 2012). No loss in body weight, no change in feed intake, nor any adverse symptoms and
mortality were observed in rats exposed to microsized red iron oxide or to 30 or 300 mg/kg bw per
day of red iron oxide nanoparticles. However, rats treated with the high dose of nano red iron oxide
(1,000 mg/kg bw per day) showed reduced body weight and feed intake, severe toxic symptoms and
several disturbances in biochemical parameters, and adverse histopathological changes in the liver,
kidney and spleen. By contrast, microsized red iron oxide did not induce any signiﬁcant adverse effects
in either biochemical parameters or histopathology in rats given the highest dose. This study indicated
that the microsized particles, i.e. bulk material, are less potent than the nanoparticles in causing
toxicity in the exposed animals. From this study, the Panel identiﬁed a no observed adverse effect level
(NOAEL) for microsized red iron oxide of 1,000 mg/kg bw per day, the highest dose tested.
No subchronic toxicity studies by oral administration of microsized yellow iron oxide, red iron oxide
or black iron oxide were available. A subchronic toxicity of red iron oxide nanoparticles (60–118 nm)
was investigated by Yun et al. (2015) in a 13-week oral toxicity study according to the OECD TG 408
(OECD, 1998). Rats received daily doses of 250, 500 or 1,000 mg/kg bw per day for 13 weeks by
gavage. Fe2O3 nanoparticles had no signiﬁcant effects on body weight, mean daily food and water
consumption when compared to control groups. There were no treatment-related changes in
haematological, serum biochemical parameters or histopathological lesions. Some changes observed in
organ weights were considered by the authors as not ‘toxicologically relevant’. In blood and all tissues
tested, including liver, kidney, spleen, lung and brain, the concentration of Fe showed no dose-
associated response in comparison to the control groups. Iron concentrations in the urine of Fe2O3
nanoparticle-treated rats showed no signiﬁcant differences compared to those of control animals. The
authors stated that the subchronic oral dosing with Fe2O3 nanoparticles showed no systemic toxicity to
rats. The Panel agreed with the conclusion of the authors and identiﬁed a NOAEL for nanosized red
iron oxide of 1,000 mg/kg bw per day, the highest dose tested in rats receiving Fe2O3 nanoparticles by
gavage. Owing to the presence of nanoparticles in red iron oxide used as food additive, the
Panel considered this study as relevant for the assessment of the safety of red iron oxide.
The Panel noted that using similar range of daily doses, adverse effects were observed in rats
subacutely treated (28 days) with red iron oxide nanoparticles whilst no effect was described after a
subchronic administration (90 days) of such particles to rats. The Panel considered that this difference
could be explained by the use of smaller nanoparticles (30 nm) in the subacute study than those used
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in the subchronic toxicity study (60–118 nm). The former could be more efﬁciently available to organs
and tissues leading to more severe adverse effects.
Red and black iron oxides, both in nano- and microform (7–30 nm and > 100 nm, respectively),
were positive in in vitro genotoxicity assays in mammalian cells, where induction of DNA strand breaks
and micronuclei was observed. In vivo oral administration of both nano- and microsized red iron
oxides did not elicit genotoxic effects in rat haemopoietic system, while no data are available for the
site-of-contact (gastrointestinal tract). No in vivo genotoxicity studies have been performed on black
iron oxide and no genotoxicity studies are available for yellow iron oxide. Due to the limitations of the
database, and considering the impossibility to read across between iron oxides with different redox
state, the Panel considered that the genotoxicity of iron oxides cannot be evaluated based on the
available data.
Concerning long-term toxicity and carcinogenicity, no adverse effects were reported in ten dogs
maintained from 1 to 9 years on diets containing iron oxide colourant (unspeciﬁed compound); the
daily consumption was estimated at 428 mg/dog (unpublished study from Carnation Co., 1967, as
reported by JECFA, 1983). In a study from Ralston Purina Cat Care Center (1968), no adverse effects
were reported in cats maintained on diets containing 1,900 mg/kg diet (475 mg/kg bw per day) of
iron from iron oxide (equivalent to 0.27% iron oxide) for periods of 2–9 years. The IARC Monograph
(IARC, 1987) stated that there was evidence suggesting lack of carcinogenicity of haematite (red iron
oxide) and ferric oxide (unspeciﬁed compound) to animals, and that there was inadequate evidence of
carcinogenicity in humans.
Concerning reproductive and developmental toxicity, no signs of toxicity were observed in an
unpublished study (as reported in JECFA, 1983). However, this study was not available and could not
be evaluated by the Panel.
The ANS Panel concluded that an adequate assessment of the safety of E 172 (iron oxides) could
not be carried out because a sufﬁcient biological and toxicological database was not available. The
ANS Panel concluded also that ‘in vivo genotoxicity data on red iron oxide at the site of contact are
absent’.
The FEEDAP Panel expresses in the current opinion its concern on the safety of ferric oxide as
compound of trace element as long as such a genotoxicity study is not provided.
3.2.2. Safety for the target species
Before assessing the safety of compounds of iron under application, the FEEDAP Panel made a
comparison between the currently authorised maximum iron (total) contents set by Regulation (EC)
No 1334/2003, the maximum tolerable levels (MTLs) published by the National Research Council of the
USA in 2005 (NRC, 2005) and similar values which could be derived from other more recent
publications. The FEEDAP Panel concluded in ﬁve scientiﬁc opinions on different compounds of iron
(EFSA FEEDAP Panel, 2013, 2014a,b, 2015, 2016a) that they are safe when supplied up to a maximum
iron content per kilogram complete feedingstuff of 450 mg for bovines and poultry, 500 mg for ovines,
600 mg for pets, and 750 mg for other species/categories, except horses and ﬁsh; for piglets up to
1 week before weaning a daily maximum dose of 250 mg Fe is considered safe. Because of insufﬁcient
data, the FEEDAP Panel was not in a position to derive a maximum safe iron concentration in feed for
horses or ﬁsh.
When assessing the ferric oxide red, the compound under assessment, the FEEDAP Panel sees no
reason to modify its above conclusions.
No tolerance study was provided to support the safety of ferric oxide for the target species.
The FEEDAP Panel has just adopted an opinion on the safety and efﬁcacy of iron oxide black, red
and yellow intended for use as colourings in animal nutrition (EFSA FEEDAP Panel, 2016b). The iron
oxide red is chemically identical to the ferric oxide under application. The Panel stated there that
Iron compounds with low water solubility, such as iron oxides, are considered to be inefﬁcient
dietary sources of iron (NRC, 1998). In studies in piglets, sheep, calves and chickens with different iron
sources, ferric oxide showed negligible or no effects on haematological parameters and/or
performance of these animal species (Bell and Tucker, 1963; Ammerman et al., 1967; Willingham and
Hill, 1970; Ammerman and Miller, 1972; Cornelius and Harmon, 1976). In rats, 0.01–2.3% of the total
oral dose of microsized red iron oxide (Fe2O3) was absorbed and distributed in different organs or
excreted in urine (EFSA ANS Panel, 2015). Suttle (2010) considered ferric oxide, used as a colouring
agent, as being among the poorest of inorganic iron sources although it is capable of impairing copper
absorption. It should be noted that ferric oxide has been used as an indigestible marker in digestibility
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studies. It is well known that dietary factors modify non-haem iron absorption, e.g. ascorbic acid
would increase iron absorption whilst phytate, calcium and polyphenols would decrease (Suttle, 2010).
Although the iron status of the organism plays an important role, high iron stores are related to low
absorption rates and vice versa.
In the same opinion (EFSA FEEDAP Panel, 2016b), ‘the FEEDAP Panel concluded that (i) a
substantial absorption of iron oxides as such is not expected; (ii) iron from the iron oxides black, red
and yellow will pass the gastrointestinal tract of target animals essentially unchanged, and (iii) iron
from the iron oxides will therefore not measurably contribute to the iron metabolism of target animals’.
Considering these aspects, iron from ferric oxide would be equally safe as ineffective in meeting the
iron demands of animals.
The FEEDAP Panel noted that as (i) the application of ferric oxide red is for all animal species,
(ii) lifetime administration to animals is not excluded and (iii) a sufﬁcient biological and toxicological
database was not available, no conclusion on the safety of ferric oxide for the target animals could be
made.
3.2.3. Safety for the consumer
Regarding (i) the very low absorption of iron from ferric oxide by target animals and (ii) the
homoeostatic regulation of iron metabolism in animals, any inﬂuence of feeding the ferric oxide on the
iron content of edible tissues and products is not expected.
Although there are no data regarding the occurrence and the biological fate of nano- and
microparticles of iron oxide, the use of ferric oxide in animal nutrition is unlikely to result in a direct
exposure of the consumer to this oxide.
The FEEDAP Panel concludes that the supplementation of feed for food-producing animals with
ferric oxide under assessment would likely not constitute a risk to consumers.
3.2.4. Safety for the user
No speciﬁc studies were provided by the applicant regarding the toxicity of the additive for the
users.
3.2.4.1. Effects on the eyes and skin
Iron oxides are common additives to cosmetic products. They are usually non-toxic, no allergic and,
inclusively, a claim that topical iron chelators might represent a novel and simple approach to prevent
skin ageing was recently reported (Pouillot et al., 2013).
Mechanical irritation of skin and eyes may occur depending on the particle size.
The nickel content of the additive is up to 107 mg/kg; given its well-known sensitisation potential
(European Commission, 2011), it would be prudent to consider the additive as dermal and respiratory
sensitiser (Nemery, 1990; Schnabel et al., 2010; Klein and Costa, 2015).
3.2.4.2. Effects on the respiratory system
Taking into consideration the high dusting potential (up to 2.7 g/m3), exposure of the lungs is likely
if the dust is inhaled.
The International Agency for Research on Cancer (IARC) of the World Health Organization (WHO)
noted that epidemiological studies of miners potentially exposed to iron ore dust or iron oxide had an
increased risk of developing lung cancer, although it was not clear whether the cancer was caused by
exposure to radiation or dust in the mines (WHO-IARC, 1972). Studies in mice, hamsters and guinea
pigs showed no increased risk of cancer with inhalatory or intratracheal exposure to iron oxides. The
IARC concluded that ferric oxide is not classiﬁable as to its carcinogenicity to humans (Group 3)
(WHO-IARC, 1987).
A limit for occupational exposure of iron oxide of 5 mg/m3 was recommended by the American
Conference of Governmental Industrial Hygienist (ACGIH, 2006). Regarding the high dusting potential
of the additive under application, this value may be exceeded by more than two orders of magnitude
during handling the product. Thus, the FEEDAP Panel considers that the additive could pose a health
risk upon inhalation.
The nickel content of the additive under assessment was provided and is up to 107 mg/kg.
Inhalation of nickel can cause pulmonary toxicity, resulting in bronchitis, ﬁbrosis and lung cancer in
humans. The proposed occupational exposure limit (OEL) for the inhalable fraction of water soluble
nickel is 0.01 mg Ni/m3 (European Commission, 2011). The dusting potential of the products
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amounted up to 2.7 g/m3, corresponding to about 0.290 mg Ni/m3; therefore, the nickel OEL is
exceeded by more than one order of magnitude.
The FEEDAP Panel assessed the user exposure resulting from the residual content of chromium in
ferric oxide. Using the highest values as a worst-case assumption (dusting potential up to 2.7 g/m3,
chromium content in the additive up to 404 mg/kg, corresponding to 1.09 mg Cr/m3 dust), the
calculated value would be above the threshold limit value set by the ACGIH (2004; 10 lg/m3 threshold
limit value (TLV), time-weighted average (TWA), insoluble Cr(VI) compounds), the action level set by
the Occupational Safety & Health Administration (OSHA, 2009; 2.5 lg Cr(VI)/m3 for an 8-h TWA
exposure) and the more recent from the National Institute for Occupational Safety and Health (NIOSH,
2013; recommended exposure limit 0.2 lg Cr(VI)/m3 for an 8-h TWA exposure, 40-h working week).
Considering the magnitude by which these thresholds are exceeded, the FEEDAP concludes that the
content of chromium gives rise to a concern for user safety.
The FEEDAP Panel recognises that (i) the use of the TLV or OEL as guidance values for user safety
of feed additives may result in overly conservative assessments, as the exposure is unlikely to be so
continuous and intense as in an industrial scenario, for which TLVs/OELs have been envisaged, and
(ii) no speciation of chromium in ferric oxide was available. Nevertheless, even with the mentioned
caveats, a concentration of iron, nickel or chromium in the inhalable dust exceeding the guidance
values by at least one order of magnitude points to a risk by inhalation for users.
3.2.4.3. Conclusions on safety for the user
Ferric oxide is irritant to skin and eyes by mechanical action. Owing to the nickel content in the
additive, ferric oxide should be considered as dermal and respiratory sensitiser.
Inhalation of ferric oxide, chromium and nickel is a hazard; as exposure by inhalation is likely,
handling ferric oxide would be a risk for the users.
As there is concern about the possible genotoxicity of ferric oxide, any route of exposure should be
considered as hazardous.
3.2.5. Safety for the environment
Iron oxides are ubiquitous in the environment. Any additional input from the nutritional use in food-
producing animals is considered negligible. Moreover, ferric oxide is insoluble in water, and iron from
this compound has a very low bioavailability. It is unlikely that the use of ferric oxide in animal
nutrition would pose a risk to the environment.
3.3. Efﬁcacy
According to a review of Henry and Miller (1995), ferric oxide has a low bioavailability in different
animal species; the authors summarised the relative bioavailability of ferric oxide compared to ferrous
sulfate monohydrate (set at 100%) for poultry and pigs as 10% and for sheep and rats as 5%. The
NRC (1998) reported a bioavailability of zero. Suttle (2010) stated that ferric oxide is among the
poorest sources of inorganic iron and dissuaded from its use in animal feeds. Moreover, ferric oxide is
routinely used as an indigestible marker in e.g. digestibility studies (Kerr et al., 2015).
Considering the vital role of iron in haemoglobin synthesis and the need of particularly young
animals for immediate keeping the requirements, ferric oxide is not considered an efﬁcacious source of
iron. Sporadic ﬁndings of a certain and even higher availability are not considered controversial; the
use of ferric oxide as iron source would, in case of not providing available iron, severely impair animal
health and welfare.
In summary, ferric oxide should not be considered as iron source capable to meet iron
requirements of animals.
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation45 and good
manufacturing practice.
45 Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down requirements for
feed hygiene. OJ L 35, 8.2.2005, p. 1.
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4. Conclusions
The FEEDAP Panel cannot conclude on the safety of ferric oxide for the target animals owing to
that (i) the application of ferric oxide red is for all animal species, (ii) lifetime administration to animals
is not excluded and (iii) a sufﬁcient biological and toxicological database was not available.
Regarding (i) the very low absorption of iron from the ferric oxide by target animals and (ii) the
homoeostatic regulation of iron metabolism in animals, any inﬂuence of feeding the ferric oxide on the
iron content of edible tissues and products is not expected. The use of ferric oxide in animal nutrition is
unlikely to result in a direct exposure of the consumer to this oxide. Consequently, the supplementation of
feed for food-producing animals with ferric oxide would likely not constitute a risk to consumers.
Ferric oxide is an irritant to skin and eyes by mechanical action. Owing to the nickel content in the
additive, the ferric oxide should be regarded as dermal and respiratory sensitiser. Inhalation of ferric
oxide, nickel and chromium is a hazard; since exposure by inhalation is likely, handling ferric oxide
would be a risk for the users. As there is concern about the possible genotoxicity of ferric oxide, any
route of exposure should be considered as hazardous.
Iron oxides are ubiquitous in the environment. Any additional input from the nutritional use of ferric
oxide in food-producing animals is considered negligible. It is unlikely that the use of the additive in
animal nutrition would pose a risk to the environment.
Ferric oxide should not be considered as iron source capable to meet iron requirements of animals.
5. Recommendations
The name of the additive under application should be adjusted to the standards established by
IUPAC to ‘Iron(III) oxide’.
A speciﬁcation should be set for ﬂuorine and that of mercury should be adjusted to reﬂect
analytical values.
Based on considerations of animal safety, the FEEDAP Panel recommends the modiﬁcation of some
of the currently authorised maximum iron contents in complete feed as follows:
• from 750 to 450 mg Fe/kg for bovine and poultry
• from 1,250 to 600 mg Fe/kg for pets
6. General remark
The FEEDAP Panel is not in a position to derive a maximum safe iron concentration in feed for
horses or ﬁsh due to insufﬁcient available data. As a provisional measure, the current value for other
animal species (750 mg Fe/kg) could be maintained. In the view of the FEEDAP Panel, additional data
are required to conﬁrm or modify the current maximum iron content in feed for horses and ﬁsh.
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ACGIH American Conference of Governmental Industrial Hygienists
ADI acceptable daily intake
ANS Panel EFSA Panel on Food Additives and Nutrient Sources added to Food
bw body weight
CAS Chemical Abstracts Service
EEC European Economic Community
EURL European Union Reference Laboratory
FAO Food and Agriculture Organization of the United Nations
FEEDAP Panel EFSA Panel on Additives and Products or Substances used in Animal Feed
IARC International Agency for research on Cancer
IUPAC International Union of Pure and Applied Chemistry
JECFA Joint FAO/WHO Expert Committee on Food Additives
MTL maximum tolerable level
NIOSH National Institute for Occupational Safety and Health
NOAEL no observed adverse effect level
NRC National Research Council
OECD Organisation for Economic Co-operation and Development
OEL occupational exposure limit
OSHA Occupational Safety & Health Administration
PCBs polychlorinated biphenyls
PCDDs polychlorinated dibenzo-para-dioxins
TEQ toxic equivalent factor
TG Technical Guidance
TLV threshold limit value
TWA time-weighted average
WHO World Health Organization
XRF X-ray ﬂuorescence
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Appendix A – List of Risk Assessment Reports on iron and iron compounds
In addition to the reports cited in the Background section, risk assessments from other the
European Union (EU) bodies and Institutions have been carried out.
1) EU risk assessment reports
Food Standard Agency Risk Assessment iron (http://www.food.gov.uk/multimedia/pdfs/evm_iron.pdf).
Scientiﬁc Advisory Committee on Nutrition Assessment iron (http://www.sacn.gov.uk/pdfs/sacn_iron_
and_health_report_web.pdf).
2) EFSA ANS Panel opinions
Iron (II) taurate, magnesium taurate and magnesium acetyl taurate as sources of iron or
magnesium added for nutritional purposes in food supplements – Scientiﬁc Opinion of the Panel on
Food Additives and Nutrient Sources added to Food (http://www.efsa.europa.eu/en/efsajournal/doc/
947.pdf).
Ferrous phosphate added for nutritional purposes to food supplements – Scientiﬁc Opinion of the
Panel on Food Additives and Nutrient Sources added to Food (http://www.efsa.europa.eu/en/
efsajournal/doc/951.pdf).
Chromium(III)-, iron(II)- and selenium-humic acid/fulvic acid chelate and supplemented
humifulvate added for nutritional purposes to food supplements – Scientiﬁc Opinion of the Panel on
Food Additives and Nutrient Sources added to Food (ANS) (http://www.efsa.europa.eu/en/
efsajournal/doc/1147.pdf).
Orotic acid salts as sources of orotic acid and various minerals added for nutritional purposes to
food supplements – Scientiﬁc Opinion of the Panel on Food Additives and Nutrient Sources added to
Food (ANS) (http://www.efsa.europa.eu/en/efsajournal/doc/1187.pdf).
Scientiﬁc Opinion on the use of ferric sodium EDTA as a source of iron added for nutritional
purposes to foods for the general population (including food supplements) and to foods for particular
nutritional uses – EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) (http://
www.efsa.europa.eu/en/efsajournal/doc/1414.pdf).
Scientiﬁc Opinion on the safety of ferrous ammonium phosphate as a source of iron added for
nutritional purposes to foods for the general population (including food supplements) and to foods for
particular nutritional uses – EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS)
(http://www.efsa.europa.eu/en/efsajournal/doc/1584.pdf).
Scientiﬁc Opinion on the safety of heme iron (blood peptonates) for the proposed uses as a source of
iron added for nutritional purposes to foods for the general population, including food supplements –
EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) (http://www.efsa.europa.eu/
en/efsajournal/doc/1585.pdf).
Scientiﬁc Opinion on the re-evaluation of iron oxides and hydroxides (E 172) as food additives –
EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) (http://www.efsa.europa.eu/
sites/default/ﬁles/scientiﬁc_output/ﬁles/main_documents/4317.pdf).
3) EFSA CEF Panel opinions/EFSA Reports
Scientiﬁc Opinion Flavouring Group Evaluation 42: Ion containing organic substances from chemical
group 30 (http://www.efsa.europa.eu/en/efsajournal/doc/1191.pdf).
Scientiﬁc Report of EFSA on the risk assessment of salts of authorised acids, phenols or alcohols for
use in food contact materials (http://www.efsa.europa.eu/en/efsajournal/doc/1364.pdf).
4) EFSA AFC Panel opinions
Opinion of the Scientiﬁc Panel on food additives, ﬂavourings, processing aids and materials in
contact with food (AFC) on a request from the Commission related to a 6th list of substances for food
contact materials (http://www.efsa.europa.eu/en/efsajournal/doc/161.pdf).
Opinion of the Scientiﬁc Panel on Food Additives, Flavourings, Processing Aids and Materials in
Contact with Food on a request from the Commission related to Ferrous bisglycinate as a source of
iron for use in the manufacturing of foods and in food supplements (http://www.efsa.europa.eu/en/
efsajournal/doc/299.pdf).
Opinion of the Scientiﬁc Panel on Food Additives, Flavourings, Processing Aids and Materials in
Contact with Food on a request from the Commission related to calcium, iron, magnesium, potassium
and zinc L-pidolate as sources for calcium, iron, magnesium, potassium and zinc added for nutritional
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purposes to food supplements and to foods intended for particular nutritional uses (http://
www.efsa.europa.eu/en/efsajournal/doc/495.pdf).
Opinion of the Scientiﬁc Panel on food additives, ﬂavourings, processing aids and materials in
contact with food (AFC) on a request related to a 18th list of substances for food contact materials
(http://www.efsa.europa.eu/en/efsajournal/doc/628.pdf).
5) EFSA NDA Panel opinions
Opinion of the Scientiﬁc Panel on Dietetic Products, Nutrition and Allergies on a request from the
Commission related to the Tolerable Upper Intake Level of Iron (http://www.efsa.europa.eu/en/
efsajournal/doc/125.pdf).
Lactobacillus plantarum 299v (DSM 9843) and improve iron absorption Scientiﬁc substantiation of a
health claim related to Lactobacillus plantarum 299v (DSM 9843) and improve iron absorption
pursuant to Article 13(5) of Regulation (EC) No 1924/2006—Scientiﬁc Opinion of the Panel on Dietetic
Products, Nutrition and Allergies (http://www.efsa.europa.eu/en/efsajournal/doc/999.pdf).
Scientiﬁc Opinion on the substantiation of health claims related to iron and formation of red blood
cells and haemoglobin (ID 249, ID 1589), oxygen transport (ID 250, ID 254, ID 256), energy-yielding
metabolism (ID 251, ID 1589), function of the immune system (ID 252, ID 259), cognitive function (ID
253) and cell division (ID 368) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (http://
www.efsa.europa.eu/en/efsajournal/doc/1215.pdf).
Scientiﬁc Opinion on the substantiation of health claims related to vitamin A and cell differentiation
(ID 14), function of the immune system (ID 14), maintenance of skin and mucous membranes (ID 15,
17), maintenance of vision (ID 16), maintenance of bone (ID 13, 17), maintenance of teeth (ID 13,
17), maintenance of hair (ID 17), maintenance of nails (ID 17), metabolism of iron (ID 206), and
protection of DNA, proteins and lipids from oxidative damage (ID 209) pursuant to Article 13(1) of
Regulation (EC) No 1924/2006—EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (http://
www.efsa.europa.eu/en/efsajournal/doc/1221.pdf).
Scientiﬁc Opinion on the substantiation of health claims related to vitamin B6 and protein and
glycogen metabolism (ID 65, 70, 71), function of the nervous system (ID 66), red blood cell formation
(ID 67, 72, 186), function of the immune system (ID 68), regulation of hormonal activity (ID 69) and
mental performance (ID 185) pursuant to Article 13(1) of Regulation (EC) No 1924/2006—EFSA Panel on
Dietetic Products, Nutrition and Allergies (NDA) (http://www.efsa.europa.eu/en/efsajournal/doc/
1225.pdf).
Scientiﬁc Opinion on the substantiation of health claims related to vitamin C and protection of DNA,
proteins and lipids from oxidative damage (ID 129, 138, 143, 148), antioxidant function of lutein (ID
146), maintenance of vision (ID 141, 142), collagen formation (ID 130, 131, 136, 137, 149), function
of the nervous system (ID 133), function of the immune system (ID 134), function of the immune
system during and after extreme physical exercise (ID 144), non-haem iron absorption (ID 132, 147),
energy-yielding metabolism (ID 135), and relief in case of irritation in the upper respiratory tract (ID
1714, 1715) pursuant to Article 13(1) of Regulation (EC) No 1924/2006—EFSA Panel on Dietetic
Products, Nutrition and Allergies (NDA) (http://www.efsa.europa.eu/en/efsajournal/doc/1226.pdf).
Scientiﬁc Opinion on the Substantiation of a health claim related to Iron and cognitive development
of children pursuant to Article 14 of Regulation (EC) No 1924/2006—EFSA Panel on Dietetic Products,
Nutrition and Allergies (NDA) (http://www.efsa.europa.eu/en/efsajournal/doc/1360.pdf).
Scientiﬁc Opinion on the substantiation of health claims related to iron and formation of red blood
cells and haemoglobin (ID 374, 2889), oxygen transport (ID 255), contribution to normal energy-
yielding metabolism (ID 255), reduction of tiredness and fatigue (ID 255, 374, 2889),
biotransformation of xenobiotic substances (ID 258), and ‘activity of heart, liver and muscles’ (ID 397)
pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (http://www.efsa.europa.eu/en/
efsajournal/doc/1740.pdf).
Scientiﬁc Opinion on the substantiation of health claims related to various food(s)/food constituent(s)
and improved bioavailability of nutrients (ID 384, 1728, 1752, 1755), energy and nutrient supply
(ID 403, 413, 457, 487, 667, 1675, 1710, 2901, 4496) and presence of a nutrient in the human body
(ID 720) pursuant to Article 13(1) of Regulation (EC) No 1924/2006—EFSA Panel on Dietetic Products,
Nutrition and Allergies (NDA) (http://www.efsa.europa.eu/en/efsajournal/doc/1743.pdf).
Scientiﬁc Opinion on the substantiation of health claims related to riboﬂavin (vitamin B2) and
contribution to normal energy-yielding metabolism (ID 29, 35, 36, 42), contribution to normal
metabolism of iron (ID 30, 37), maintenance of normal skin and mucous membranes (ID 31, 33),
contribution to normal psychological functions (ID 32), maintenance of normal bone (ID 33),
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maintenance of normal teeth (ID 33), maintenance of normal hair (ID 33), maintenance of normal
nails (ID 33), maintenance of normal vision (ID 39), maintenance of normal red blood cells (ID 40),
reduction of tiredness and fatigue (ID 41), protection of DNA, proteins and lipids from oxidative
damage (ID 207), and maintenance of the normal function of the nervous system (ID 213) pursuant
to Article 13(1) of Regulation (EC) No 1924/2006 – EFSA Panel on Dietetic Products, Nutrition and
Allergies (NDA) (http://www.efsa.europa.eu/en/efsajournal/doc/1814.pdf).
Scientiﬁc Opinion on the substantiation of health claims related to meat or ﬁsh and the
improvement of non-haem iron absorption (ID 1223) pursuant to Article 13(1) of Regulation (EC) No
1924/2006 – EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (http://www.efsa.
europa.eu/en/efsajournal/doc/2040.pdf).
Scientiﬁc Opinion on the substantiation of a health claim related to iron and maintenance of normal
hair growth pursuant to Article 13(5) of Regulation (EC) No 1924/2006 – EFSA Panel on Dietetic Products,
Nutrition and Allergies (NDA) (http://www.efsa.europa.eu/sites/default/ﬁles/scientiﬁc_output/ﬁles/
main_documents/2602.pdf).
Scientiﬁc Opinion on bovine lactoferrin – EFSA Panel on Dietetic Products, Nutrition and Allergies
(http://www.efsa.europa.eu/en/efsajournal/doc/2701.pdf).
Scientiﬁc Opinion on Dietary Reference Values for iron – EFSA Panel on Dietetic Products, Nutrition
and Allergies (http://www.efsa.europa.eu/sites/default/ﬁles/scientiﬁc_output/ﬁles/main_documents/
4254.pdf).
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Appendix B – List of authorisations of iron compounds other than as feed
additives
The following iron compounds are authorised for use in food (Regulation (EC) No 1170/2009)46:
ferrous L-pidolate, ferrous phosphate, iron (II) taurate which may be used in the manufacture of food
supplements; ferrous carbonate, ferrous citrate, ferrous ammonium citrate, ferrous gluconate, ferrous
fumarate, ferric sodium diphosphate, ferrous lactate, ferrous sulfate, ferric diphosphate (ferric
pyrophosphate), ferric saccharate, elemental iron (carbonyl + electrolytic + hydrogen reduced) and
ferrous bisglycinate which may be used in the manufacture of food supplements and may be added to
food. Ferrous gluconate (579) and ferrous lactate (E 585) are authorised as food additives for use in
olives darkened by oxidation at the maximum level of 150 mg/g as Fe (European Parliament and
Council Directive No 95/2/EC).47
The following iron compounds can be used for the manufacturing of dietetic foods (Commission
Regulation (EC) No 953/2009)48: ferrous carbonate, ferrous citrate, ferrous ammonium citrate, ferrous
gluconate, ferrous fumarate, ferric sodium diphosphate, ferrous lactate, ferrous sulfate, ferric
diphosphate (ferric pyrophosphate), ferric saccharate, elemental iron (carbonyl + electrolytic +
hydrogen reduced), ferrous bisglycinate and ferrous L-pidolate.
The following iron compounds can be used for the manufacturing of processed cereal-based foods
and baby foods for infants and young children (Commission Directive 2006/125/EC)49: ferrous citrate,
ferrous ammonium citrate, ferrous gluconate, ferrous lactate, ferrous sulfate, ferrous fumarate, ferric
diphosphate (ferric pyrophosphate), elemental iron (carbonyl + electrolytic + hydrogen reduced), ferric
saccharate, sodium ferric diphosphate and ferrous carbonate.
Regarding pharmacologically active substances and their classiﬁcation regarding maximum residue
limits in foodstuffs of animal origin, the following iron compounds are listed in table 1 of the Annex of
Regulation 37/201050 as Allowed substances, no MRL required: iron ammonium citrate, iron dextran,
iron dichloride, iron fumarate, iron glucoheptonate and iron sulfate.
The following iron compounds are listed in Annex of Commission Implementing Regulation (EU)
40/201151 as ‘Active substances approved for use in plant protection products’: iron sulfate, iron (II)
sulfate anhydrous, iron (II) sulfate monohydrate, iron (II) sulfate heptahydrate (iron (II) sulfate) and
ferric phosphate.
The following type of fertilisers for iron are listed in Annex I of Regulation (EC) No 2003/2003 of
the European Parliament and of the Council as Fertilisers containing only one micro-nutrient52: (a) iron
salt (chemically obtained product containing a mineral iron salt as its essential ingredient); (b) iron
chelate (water soluble product obtained by chemical reaction of iron with chelating agents mentioned
in the list of Annex I chapter E.3 which are sodium, potassium or ammonium acids or salts of EDTA,
DTPA, EDDHA, HEEDTA, EDDHMA, EDDCHA) and iron fertiliser solution (product obtained by dissolving
types (a) and/or one of the type (b) in water).
The following iron compounds can be used for cosmetic purposes (Regulation (EC) No 1223/2009
of the European Parliament and of the Council53): iron oxide, iron oxide red, iron oxide yellow, iron
oxide black, ferric ammonium ferrocyanide, aluminium silicate coloured with ferric oxide and natural
hydrated aluminium silicate, Al2O32SiO22H2O with iron carbonates or ferric hydroxide impurities.
46 Commission Regulation (EC) No 1170/2009 of 30 November 2009 amending Directive 2002/46/EC of the European Parliament
and of Council and Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards the lists of
vitamin and minerals and their forms that can be added to foods, including food supplements. OJ L 314, 1.12.2009, p. 36.
47 European Parliament and Council Directive No 95/2/EC of 20 February 1995 on food additives other than colours and
sweeteners. OJ L 61, 18.3.1995, p. 1.
48 Commission Regulation (EC) No 953/2009 of 13 October 2009 on substances that may be added for speciﬁc nutritional
purposes in foods for particular nutritional uses. OJ L 269, 14.10.2009, p. 9.
49 Commission Directive 2006/125/EC of 5 December 2006 on processed cereal-based foods and baby foods for infants and
young children. OJ L 339, 6.12.2006, p. 16.
50 Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classiﬁcation
regarding maximum residue limits in foodstuffs of animal origin. OJ L 15, 20.1.2010, p. 1.
51 Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the
European Parliament and of the Council as regards the list of approved active substances. OJ L 153, 11.6.2011, p. 1.
52 Regulation (EC) No 2003/2003 of the European Parliament and of the Council of 13 October 2003 relating to fertilisers. OJ L
304, 21.11.2003, p. 1.
53 Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products. OJ
L 342, 22.12.2009, p. 59.
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According to the Annex of Regulation (EC) No 432/201254, the following health claims can be made
only for food which is at least a source of iron as referred to in the claim SOURCE OF [NAME OF
VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation (EC) No 1924/200655:
iron contributes to normal cognitive function, iron contributes to normal energy-yielding metabolism, iron
contributes to normal formation of red blood cells and haemoglobin, iron contributes to normal oxygen
transport in the body, iron contributes to the normal function of the immune system, iron contributes to
the reduction of tiredness and fatigue and iron has a role in the process of cell division.
54 Commission Regulation (EC) No 432/2012 of 16 May 2012 establishing a list of permitted health claims made on foods, other
than those referring to the reduction of disease risk and to children’s development and health. OJ L 136, 25.5.2012, p. 1.
55 Regulation (EC) No 1924/2006 of the European Parliament and of the council of 20 December 2006 on nutrition and health
claims made for food. OJ L 404, 30.12.2006, p. 9.
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Appendix C – Iron content in animal tissues and products: food
composition tables
Table C.1: Iron content of animal tissues (liver, kidney and muscle) and products (egg and milk):
data derived from food composition tables
Species/
category
Liver
(mg Fe/kg)
Kidney
(mg Fe/kg)
Muscle
(mg Fe/kg)
Egg
(mg Fe/kg)
Milk
(mg Fe/kg)
Reference
Swine
Pigs 33 5.5–7.1 (c)
180(a) 12–17 (d)
170 (150–310) 73 (53–150) 10 (10–11) (e)
Ruminants
Veal 60.8 14.5–16 (c)
12 (d)
55 (57–93) 120 (79–150) 21 (15–26) (e)
Cattle 16–24.7 (c)
88 80 13–19 (d)
69 (44–72) 110 (65–150) 21 (17–23) (e)
Dairy cattle 0.6 (c)
1 (d)
0.46 (0.3–0.7) (e)
Lamb 12–22 (c)
17–20 (d)
Sheep 126 1 (e)
120 (120–130) 75 (41–92) 18 (15–23) 0.58 (0.51–1.0) (c)
Goat 1 (d)
0.41 (0.36–0.75) (e)
Poultry
Chickens 90.15 18 (c)
6–14 (d)
74 7.3 (6–20) (e)
Laying hens 70.6 8–10.1 20 55 [yolk] (c)
15 (d)
18 (e)
72 (51–120)
[yolk]
Hens 16 (d)
Turkey 7.7 (c)
9–10 (d)
Duck 300.5 12 38.5 (c)
13 (d)
Goose 25 36.4 (c)
290.6 18 (d)
Rabbits 10 (d)
27 (18–60) (e)
Horses 35 (c)
90 39 (d)
49 (e)
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Species/
category
Liver
(mg Fe/kg)
Kidney
(mg Fe/kg)
Muscle
(mg Fe/kg)
Egg
(mg Fe/kg)
Milk
(mg Fe/kg)
Reference
Fish
Cod 23 (d)
Herring 13 (c)
9 (d)
9.8 (5.9–10) (e)
Mackerel 12 (d)
12 (8–14) (e)
Eel 10 (d)
Trout 7 (c)
20(b) (d)
4.1 (e)
Tuna 15 (c)
13 (d)
Carp 10 (d)
7 (6–13) (e)
Salmon 8 (c)
7 (d)
5.8 (4–15) (e)
(a): Data are reported as from the reference, i.e. as a single ﬁgure, as average (and range) or as a range.
(b): Farmed trout.
(c): Danish Food Consumption Databank – Ed. 7.01. National Food Institute – Technical University of Denmark.
http://www.foodcomp.dk/v7/fcdb_foodnutrlist.asp?CompId=0061
(d): Database of INRAN – Italian National Institute for Research on Foods and Nutrition.
http://www.inran.it/646/tabelle_di_composizione_degli_alimenti.html
(e): Souci SW, Fachmann W and Kraut H, 2008. Food composition and nutrition tables. 7th Edition, MedPharm Scientiﬁc
Publisher, Stuttgart, Germany; and CRC Press, Taylor and Francis Group, LLC, Boca Raton, Florida, USA.
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Annex A – Executive Summary of the Evaluation Report of the European
Union Reference Laboratory for Feed Additives on the Method(s) of
Analysis for Iron (E1)
In the current application authorisation is sought under articles 4(1) and 10(2) for ferrous chelate
of glycine hydrate,1 ferrous/iron chelate of amino acids hydrate,1,2 ferrous fumarate,1 ferric oxide,3
ferric chloride hexahydrate,1 ferrous sulfate monohydrate,1,4 ferrous sulfate heptahydrate,1,5 ferrous
carbonate6 under the category/functional group (3b) ‘nutritional additives’/‘compounds of trace
elements’, according to the classiﬁcation system of Annex I of Regulation (EC) No 1831/2003.
Speciﬁcally, authorisation is sought for the use of these feed additives for all categories and species.
According to the Applicants ferrous chelate of glycine hydrate is a green-gray free-ﬂowing powder
with a minimum content of 17% total iron, ferrous/iron chelate of amino acids hydrate is a brown free-
ﬂowing powder with a minimum content of 10% total iron, ferrous fumarate is white reddish powder
with a minimum content of 30% total iron, ferric oxide is a red brown powder with a minimum content
of 56% total iron, ferric chloride hexahydrate is a yellow brown solid aggregate with a minimum
content of 59% total iron, ferrous sulfate monohydrate consists of beige to gray free-ﬂowing granules
with a minimum content of 29% total iron, ferrous sulfate heptahydrate is a blue-green crystalline
powder with a minimum content of 18% total iron and ferrous carbonate is a brown powder with a
minimum content of 37% total iron. These feed additives are intended to be mixed into premixtures,
feedingstuffs and/or water(*). The Applicants suggested maximum levels ranging from 250 to
1,250 mg total iron/kg feedingstuffs and from 100 to 2,273 mg total iron/L water, similar to limits set
in the previous regulations.
For the identiﬁcation and quantiﬁcation of the inorganic iron compounds (i.e. ferrous fumarate,
ferric chloride hexahydrate and ferrous sulphate mono and heptahydrate) in the feed additive, the
EURL recommends for ofﬁcial control the relevant titrimetric methods described in the European
Pharmacopoeia Monographs 0083, 0902 and 1515. As for the identiﬁcation of ferrous carbonate and
ferric oxide the EURL recommends using X-ray diffraction.
For the determination of ferric oxide (also known as iron oxide red) in the feed additive the
internationally recognised FAO JECFA monograph for food additives is recommended by Commission
Directive 2008/128/EC, laying down speciﬁc purity criteria concerning colours for use in foodstuffs.
Identiﬁcation is based on solubility in solvents, while quantiﬁcation is based on digestion and
iodometric titration.
For the quantiﬁcation of ‘amino’ content in the amino iron chelates (i.e. ferrous chelate of glycine
hydrate and ferrous/iron chelate amino acids hydrate), the Applicant proposed the Community method
based on ion exchange chromatography combined with post-column ninhydrin derivatisation and
photometric detection at 570 nm. The EURL considers the Community method suitable for the
characterisation of the amino compounds in the frame of ofﬁcial control.
Furthermore, the EURL identiﬁed the generic European Pharmacopoeia methods for the
‘identiﬁcation reactions of ions and functional groups’, such as carbonate, chloride and sulfate in the
feed additives. Finally, the EURL recommends crystallographic techniques, such as X-Ray diffraction for
the characterisation of crystalline structures of ferric oxide, ferric chloride hexahydrate, ferrous
carbonate and ferrous sulfate mono and heptahydrate.
For the quantiﬁcation of total iron in the feed additives, premixtures and feedingstuffs the
Applicants submitted three ring trial validated CEN methods: EN 6869, based on atomic absorption
spectrometry (AAS), EN 15510, based on inductively coupled plasma atomic emission spectroscopy
(ICP-AES) and CEN/TS 15621, based on ICP-AES after pressure digestion. Precisions ranging from 2%
to 16% were reported, together with limits of quantiﬁcation (LOQ) ranging from 1 to 5 mg/kg
feedingstuffs. Furthermore, the EURL identiﬁed the comparative trial organised by the UK Food
Standards Agency, based on the Community method for the determination of iron in feedingstuffs, in
which precisions ranging from 1.0% to 9.5% were reported.
For the quantiﬁcation of total iron in water the Applicant (FAD-2010-0095) submitted the ring trial
validated method EN ISO 11885, based on ICP-AES. The following performance characteristics were
1 FAD-2010-0095.
2 FAD-2010-0068.
3 FAD-2010-0236.
4 FAD-2010-0295.
5 FAD-2010-0296.
6 FAD-2010-0380.
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reported: a relative standard deviation for repeatability (RSDr) ranging from 1.5% to 2.4%, a relative
standard deviation for reproducibility (RSDR) ranging from 4.9% to 5.9%, and LOQ = 1 lg/L.
Based on the available performance characteristics the EURL recommends for ofﬁcial control all the
above mentioned CEN methods together with the Community method to quantify total iron content in
the feed additives, premixtures, feedingstuffs and/or water.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005) is not
considered necessary.
(*) not for ferric oxide, ferrous carbonate and ferrous chelate of amino acids hydrate.
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